1. Home
  2. FIVE vs BBIO Comparison

FIVE vs BBIO Comparison

Compare FIVE & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Below Inc.

FIVE

Five Below Inc.

HOLD

Current Price

$192.95

Market Cap

12.6B

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$67.48

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIVE
BBIO
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
12.7B
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
FIVE
BBIO
Price
$192.95
$67.48
Analyst Decision
Buy
Strong Buy
Analyst Count
20
25
Target Price
$236.00
$86.33
AVG Volume (30 Days)
1.3M
2.8M
Earning Date
06-03-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
40.65
N/A
EPS
2.21
N/A
Revenue
$4,764,147,000.00
$502,076,000.00
Revenue This Year
$14.44
$89.45
Revenue Next Year
$9.37
$73.78
P/E Ratio
$29.66
N/A
Revenue Growth
22.90
126.26
52 Week Low
$121.11
$38.57
52 Week High
$251.63
$84.94

Technical Indicators

Market Signals
Indicator
FIVE
BBIO
Relative Strength Index (RSI) 32.40 46.98
Support Level $183.64 $62.37
Resistance Level $236.33 $69.85
Average True Range (ATR) 8.21 2.77
MACD -2.28 0.10
Stochastic Oscillator 3.90 46.43

Price Performance

Historical Comparison
FIVE
BBIO

About FIVE Five Below Inc.

Five Below Inc is a specialty value retailer offering a broad range of trend-right, high-quality products loved by the kid and the kid in all of customers. The Company's edited assortment of products includes select brands and licensed merchandise. The Company also sells its merchandise on the internet, through the Company's e-commerce website and mobile app, offering home delivery and the option to buy online and pick up in store. Additionally, the Company sells merchandise through on-demand third-party delivery services to enable its customers to shop online and receive convenient delivery. It derives revenue from sales of the Company's merchandise to customers.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: